医学分子生物学杂志 ›› 2022, Vol. 19 ›› Issue (1): 85-89.doi: 10.3870/j.issn.1672-8009.2022.01.014

• 综述 • 上一篇    下一篇

皮瓣缺血再灌注损伤治疗研究进展

  

  1. 1甘肃中医药大学中医临床学院 兰州市, 730030  2甘肃省中医院手外科 兰州市, 730050
  • 出版日期:2022-01-31 发布日期:2022-02-25
  • 基金资助:
    国家自然科学基金地区科学基金项目(No. 81860863)

Advances in Skin Flap Ischemia-Reperfusion Injury

  • Online:2022-01-31 Published:2022-02-25

摘要: 在皮瓣移植术后常常会发生缺血再灌注损伤, 缺血再灌注损伤是引起皮瓣部分或全部坏死的重 要原因。 目前对皮瓣缺血再灌注损伤的发病机制尚不清楚, 大多数学者认为可能与细胞凋亡、 炎性反应、 组织微循环障碍、 细胞氧化损伤等有关。 学者们提出用缺血预处理, 药物干预, 减少炎性反应, 移植干细 胞或干细胞联合基因疗法, 体外冲击波, 抗氧化反应和抑制细胞凋亡等方法减轻皮瓣缺血再灌注损伤。 文 章对近年来治疗皮瓣缺血再灌注损伤的实验研究及临床应用现状进行综述, 旨在为皮瓣缺血再灌注损伤的 治疗提供理论依据和新的思路。

关键词: 皮瓣, 缺血再灌注, 损伤, 治疗

Abstract: Ischemia-reperfusion injury often occurs after skin flap transplantation, and may lead to partial or complete necrosis of the skin flap. However, the pathogenesis of flap ischemia reperfusion injury remains unclear. Previous studies imply that its pathogenesis may be related to cell apoptosis, inflammatory response, tissue microcirculation disorder, and cell oxidative damage. The treatments for reducing the flap ischemia-reperfusion injury in previous studies include the use of ischemic preconditioning, drug intervention, reduction of inflammatory response, transplantation of stem cells or stem cell-based gene therapy, extracorporeal shock wave, antioxidant response, and inhibition of cell apoptosis. This article reviews the recent experimental researches on skin flap ischemia-reperfusion injury treatment and their clinical applications, which aims to provide theoretical basis and new ideas for the treatment of skin flap ischemia-reperfusion injury.

Key words: flap, ischemia reperfusion, injury, treatment

中图分类号: